Literature DB >> 25755529

Acute Kidney Dysfunction in Patients with Chronic Hepatitis C Virus Infection: Analysis of Viral and Non-viral Factors.

Sanjaya K Satapathy1, Chandra S Lingisetty2, Susan E Williams3.   

Abstract

BACKGROUND: Multiple studies have shown a relationship between chronic hepatitis C infection and chronic kidney disease. The prevalence, severity, underlying etiologies and predictors of acute kidney dysfunction (AKD) events in patients with hepatitis C has not been studied.
METHODS: We investigated viral and non-viral factors in the development renal dysfunction in 468 HCV patients retrospectively over a period of observation ranging from 3 months to 6 yrs.
RESULTS: A total of 124 AKD events occurred in 63 patients. On regression analysis; gender, race, alcohol abuse, HIV (Human immune deficiency virus) status, body mass index, baseline viral load (HCV-PCR), and genotype did not predict an event of AKD. Decompensated liver disease, history of IVDU, diabetes mellitus and baseline creatinine were independent predictors of AKD.
CONCLUSION: Development of AKD in patient with hepatitis C virus infection is independent of the genotype and viral load at baseline and is mostly predisposed by known prevalent factors in patients with hepatitis C such as diabetes, hypertension and intravenous drug use. Decompensated liver disease is the single most viral-related factor that predisposes for AKD.

Entities:  

Keywords:  ADQI, acute dialysis quality initiative; AKD, acute kidney dysfunction; ESRD, end stage renal disease; HCV, hepatitis C virus; IVDU, intravenous drug use; LVP, large volume paracentesis; acute kidney dysfunction; acute renal failure; cirrhosis; end stage renal disease; hepatitis C virus

Year:  2014        PMID: 25755529      PMCID: PMC4017169          DOI: 10.1016/j.jceh.2014.01.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  13 in total

1.  Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III].

Authors:  Magda Shaheen; Diana Echeverry; Marcela Garcia Oblad; Marie I Montoya; Senait Teklehaimanot; Abbasi J Akhtar
Journal:  Diabetes Res Clin Pract       Date:  2006-08-17       Impact factor: 5.602

2.  Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis.

Authors:  Dario Roccatello; Alessandro Fornasieri; Osvaldo Giachino; Daniela Rossi; Alessandra Beltrame; Giovanni Banfi; Roberto Confalonieri; Antonio Tarantino; Sonia Pasquali; Antonio Amoroso; Silvana Savoldi; Valeriana Colombo; Carlo Manno; Antonio Ponzetto; Luigi Moriconi; Antonello Pani; Roberto Rustichelli; Giovanni Barbiano Di Belgiojoso; Chiara Comotti; Maria Ida Quarenghi
Journal:  Am J Kidney Dis       Date:  2007-01       Impact factor: 8.860

3.  Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

Authors:  Nora Franceschini; Sonia Napravnik; Joseph J Eron; Lynda A Szczech; William F Finn
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

4.  Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis.

Authors:  C-C Wu; L-K Yeung; W-S Tsai; C-F Tseng; P Chu; T-Y Huang; Y-F Lin; K-C Lu
Journal:  Clin Nephrol       Date:  2006-01       Impact factor: 0.975

5.  Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.

Authors:  I Bica; B McGovern; R Dhar; D Stone; K McGowan; R Scheib; D R Snydman
Journal:  Clin Infect Dis       Date:  2001-01-23       Impact factor: 9.079

6.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

7.  The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

Authors:  Marina B Klein; Richard G Lalonde; Samy Suissa
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

8.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

9.  The risk for mild kidney function decline associated with illicit drug use among hypertensive men.

Authors:  Suma Vupputuri; Vecihi Batuman; Paul Muntner; Lydia A Bazzano; John J Lefante; Paul K Whelton; Jiang He
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

Review 10.  Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Rinaldo Bellomo; Claudio Ronco; John A Kellum; Ravindra L Mehta; Paul Palevsky
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

View more
  2 in total

Review 1.  Hepatitis C and kidney disease: A narrative review.

Authors:  Rashad S Barsoum; Emad A William; Soha S Khalil
Journal:  J Adv Res       Date:  2016-07-26       Impact factor: 10.479

2.  Impact of acute kidney injury on survival in patients with chronic hepatitis C: a retrospective cohort study.

Authors:  Hankyu Jeon; Jae Heon Kim; Sang Soo Lee; Hee Jin Kim; Ra Ri Cha; Hyun Chin Cho; Jae Min Lee; Chang Yoon Ha; Hyun Jin Kim; Tae Hyo Kim; Woon Tae Jung; Ok-Jae Lee
Journal:  BMC Infect Dis       Date:  2021-03-25       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.